Across the ocean, located in a manor-style villa in Texas.

Caroline, wearing a white lady's nightgown, leaned against a comfortable log lounge chair, holding a cup of coffee in her hand and savored it carefully. Her long eyelashes trembled slightly, and her beautiful ears were listening to her confidant Yudel's report:

"... Several pharmaceutical factories in the family's South Asia have received instructions. At the latest next week, the first batch of specially treated new drugs, "Gubonrui", will be packaged. Every month from now, we will get no less than 50,000 such finished products."

“… Regarding the initial large-scale clinical trial areas of new drugs, I suggest selecting one or several countries among Southeast Asian countries, consulting with local government officials, and conducting them in the name of humanitarian assistance, so that as much valuable data as possible can be received in a short period of time at the lowest cost.”

"If everything goes well, we can put this new drug, which is not inferior to Lanling No. 1, on the market on a large scale in China by the middle of next year."

Caroline frowned and pondered for a while, and asked slowly: "Why don't this area of ​​clinical human trials directly choose to conduct it in China? Anyway, this country has the largest population in the world and the largest consumer market. If Chinese people are directly used to do the experiment, the feedback data obtained should be more valuable, right?"

Yudell was surprised and quickly opposed: "This is not feasible, Miss Caroline. The Chinese government cannot allow us to do this. Since the Golden Rice case more than ten years ago, the relevant departments in China have strengthened the supervision of this aspect, so we will not get permission from the local government at all."

The so-called golden rice is a kind of genetically modified rice that has not been proven to be safe. Three unscrupulous Chinese researchers collaborated secretly with a US university and brought it into the country privately. Then, without the permission of relevant domestic departments, they took Chinese students to experiment with them.

From May 20 to June 23, 2008, the experiment containing the "Golden Rice" experimental group was carried out at Jiangkou Town Central Primary School in Hengnan County, Xiangjiang Province. The trial subjects were 80 children, randomly divided into 3 groups, of which 25 children in one group ate 60 grams of "Golden Rice" with lunch on June 2, and the remaining time and other groups of children ate locally purchased food.

After the incident was exposed, the Chinese media paid great attention to this, and relevant government departments also launched an investigation, and the three responsible persons were eventually punished.

Since then, China's supervision and approval of clinical human trials for new drugs and genetically modified foods has gradually strengthened, especially in recent years, it has become increasingly difficult for foreign companies to conduct similar trials in China to be approved.

In fact, in the past twenty years, all new drugs launched in the United States have been basically tested abroad, or selected test subjects from some illegal immigrants in China. As for legal American citizens, there are very few participations.

Pharmaceutical giants do this to make the people of developing countries act as cheap guinea pigs and develop new drugs at the lowest cost possible. As for the various implicit and explicit harms caused to the tester group in this process, they will not be responsible at all.

Caroline hopes to conduct clinical trials of drugs in China, and the intention is obvious.

"Is it okay to bribe local government officials and conduct it in secret experiments?" she asked unwillingly.

"It's very difficult, Miss Caroline."

Yudell said: "The potential risk is too great. Once this matter is exposed, we will be very passive. If it arouses the vigilance of relevant Chinese parties, many things will be difficult to do in the future."

Caroline frowned and said unwillingly: "Okay, then let's try it in Southeast Asian countries. I hope it can be completed as soon as possible, and then export it to China on a large scale. We must seize enough market share."

This new drug is the bargaining chip she challenged Zhao Xinglan and the forces behind her. She wanted to let the other party understand that the right to speak in the field of biopharmaceuticals is still in the hands of European and American pharmaceutical giants, and it is not something that Lan Ling No. 1 can easily shake.

Yudel nodded silently. As a senior executive, he naturally understood that even if the large-scale human trial plan was completed as scheduled, the safety of this new drug could not meet the current market standards in European and American countries. Therefore, in recent years, it can only be sold in China and other Asian, African and Latin America countries.

Only when the family makes enough profits and then continues to optimize and improve this drug, can it be launched on a large scale in China after the second or even the third generation of "Gubonrui" is released.

This process will last for several years, and during this period, there will be no concern about how many Chinese patients will suffer serious health damage.

...

Zhao Xinglan didn't know the plan of the American wealthy princess who had long regarded her as her opponent. She is now busy in the laboratory every day and will not return to the company headquarters every four or five days to handle some matters that must be decided by herself. It was not until the National Day in 2020 that the first batch of thirty Jingwei No. 1 was finally released.

At the press conference held, Song Shiyue finally saw the thirty crystal glass test tubes placed in the suitcase, which were encapsulated with light blue medicine liquid.

"...According to the process, this batch of new drugs will be used in mice experiments. After several phases of animal experiments are completed, volunteer patients will be summoned for clinical treatment, patents and production approval documents. If everything goes well, this drug can be put into the market in batches in three months."

In the spotlight, Zhao Xinglan, who was radiant and glamorous, slowly told the company's new drug development progress with a confident and elegant voice.

In the audience, there were many teachers and students of Binhai University, representatives of domestic and foreign pharmaceutical companies, and media reporters looked at her with incredible eyes, and all kinds of discussions were heard:

"...This is the third time, right?"

"The three new drugs were launched in a row in a year. This goddess Xinglan is really amazing! I just don't know if this Jingwei No. 1 is as powerful as it promotes!"

"There should be no problem. Just look at the effects of the previous two drugs. The IQ of this goddess is really terrible. If it means that she will produce more new drugs in the past year, I wouldn't be surprised."

"Well, indeed! My girlfriend's eyes have always been bad, and there is hope for the problem to be solved this time!"

"The three new drugs can be sure to win three Nobel Prizes. It depends on what other drugs she can come up with in the future!"

"Haha, it seems that this declaration of Baoyuan's 20-year Nobel Prize in Medicine is not completely unreasonable! Goddess Xinglan is so young and will be very long in the future. Who dares to pat her breasts and guarantee that she will not be able to do it?"
Chapter completed!